Cardiac Ablation Devices Market

Cardiac Ablation Devices Market

  • HC-546
  • 4.4 Rating
  • 190 Pages
  • Upcoming
  • 61 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

Cardiac Ablation Devices Market Outlook 2031
 

The global cardiac ablation devices market size was valued at USD XX Billion in 2022 and is projected to reach USD XX Billion by 2031, expanding at a CAGR of XX% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising prevalence of cardiovascular diseases.

Cardiac ablation is a surgical procedure that requires correction of rhythmic problems of the heart. The procedure includes scarring and deterioration of tissues that causes heart rhythm abnormality. In certain cases, cardiac ablation can help to avoid an arrhythmia. This is done by preventing irregular electrical signals to enter into the patient's heart.

Cardiac Ablation Devices Market Outlook

Cardiac ablation involves inserting long, flexible tubes called catheters into a vein or artery, which delivers energy in a form of heat or cold to the tissues in the heart that triggers an arrhythmia. Increasing number of patients suffering from cardiovascular diseases such as arrhythmia is expected to drive the demand for cardiac ablation devices in the coming years.

According to the World Health Organization (WHO), around 17 million people die each year from cardiovascular diseases. Out of the total death count, heart attacks account for nearly 85 percent of deaths.

Cardiac Ablation Devices Market Drivers, Restraints, Trends, and Opportunities

  • Rising number of people with cardiac arrhythmia and growing geriatric population are the driving the cardiac ablation devices market growth.

  • Increasing preference for minimally invasive surgeries and rising awareness regarding cardiac ablation devices are anticipated to spur the cardiac ablation devices market growth.

  • Growing number of ablation centers is speculated to boost the cardiac ablation market.

  • Stringent regulations and risks related to cardiac ablation procedures can hamper the market opportunities during the forecast period.

Scope of Cardiac Ablation Devices Market Report

The report on the global cardiac ablation devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Cardiac Ablation Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), Applications (Tachycardia, Open Surgery, and Cardiac Rhythm Management), and End-users (Hospitals, Ambulatory Surgical Centers, Clinics, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, and Abbott

Global Cardiac Ablation Devices Market Segment Insights

Electric ablators segment to account a large market share

Based on products, the cardiac ablation devices market share is segmented into cryoablation devices, radiofrequency ablators, ultrasonic ablators, and electrical ablators. In 2020, electric ablators segment to account for a large market share during the forecast period. Argon plasma/beam coagulators and irreversible electroporation devices are two types of electric ablators. Increasing number of R&D activities is driving the growth of the market segment.

Cardiac Ablation Devices Market Products

Cardiac rhythm management segment to account for key market share

In terms of applications, the cardiac ablation devices market share is segmented into tachycardia, open surgery, and cardiac rhythm management. The cardiac rhythm management to account for a key market share during the forecast period. Cardiac rhythm management devices are commonly used to treat heart disease and heart rhythmic disorders.

Cardiac Ablation Devices Market Application

Hospitals segment to dominate the market

On the basis of end-users, the market is classified as hospitals, ambulatory surgery centers, clinics, and others. In 2020, the hospital segment accounted for more than USD 1.5 billion in revenue. The presence of modern healthcare infrastructure and trained clinicians improve procedural adoption rates in the hospitals. The availability of latest technology in hospitals is driving the growth of the market segment.

North America to dominate the market

Based on regions, the market is segregated into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held a large market share owing to the rising healthcare expenditure, increasing disposable income, and the availability of latest technology are contributing to the regional market growth.

North America is expected to dominate the market during the forecast period owing to the rising prevalence of cardiac arrhythmias, established healthcare infrastructures, high volumes of catheterization, increasing government funding, and growing patient awareness in countries such as the US and Canada.

Cardiac Ablation Devices Market Regions

Segments

The global cardiac ablation devices market has been segmented based on

Products

  • Radiofrequency (RF) Ablators
  • Electrical Ablators
  • Cryoablation Devices
  • Ultrasound Ablators

Applications

  • Tachycardia
  • Open Surgery
  • Cardiac Rhythm Management

End-users

  • Hospitals
  • Ambulatory SurgicalCcenters
  • Clinics
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Some of the leading manufacturers in the global cardiac ablation devices market are Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, Abbott.

Companies are focusing on providing advanced technology devices to hospitals and clinics for the treatment of patients suffering from arrhythmia.

Cardiac Ablation Devices Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiac Ablation Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cardiac Ablation Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cardiac Ablation Devices Market - Supply Chain
  4.5. Global Cardiac Ablation Devices Market Forecast
     4.5.1. Cardiac Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cardiac Ablation Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Cardiac Ablation Devices Market Absolute $ Opportunity
5. Global Cardiac Ablation Devices Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     5.3.1. Tachycardia
     5.3.2. Open Surgery
     5.3.3. Cardiac Rhythm Management
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Cardiac Ablation Devices Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     6.3.1. Hospitals
     6.3.2. Ambulatory SurgicalCcenters
     6.3.3. Clinics
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cardiac Ablation Devices Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Cardiac Ablation Devices Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Cardiac Ablation Devices Demand Share Forecast, 2019-2026
8. North America Cardiac Ablation Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Cardiac Ablation Devices Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     8.4.1. Tachycardia
     8.4.2. Open Surgery
     8.4.3. Cardiac Rhythm Management
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     8.7.1. Hospitals
     8.7.2. Ambulatory SurgicalCcenters
     8.7.3. Clinics
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Cardiac Ablation Devices Demand Share Forecast, 2019-2026
9. Latin America Cardiac Ablation Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     9.4.1. Tachycardia
     9.4.2. Open Surgery
     9.4.3. Cardiac Rhythm Management
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     9.7.1. Hospitals
     9.7.2. Ambulatory SurgicalCcenters
     9.7.3. Clinics
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Cardiac Ablation Devices Demand Share Forecast, 2019-2026
10. Europe Cardiac Ablation Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Cardiac Ablation Devices Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     10.4.1. Tachycardia
     10.4.2. Open Surgery
     10.4.3. Cardiac Rhythm Management
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     10.7.1. Hospitals
     10.7.2. Ambulatory SurgicalCcenters
     10.7.3. Clinics
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Cardiac Ablation Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Cardiac Ablation Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     11.4.1. Tachycardia
     11.4.2. Open Surgery
     11.4.3. Cardiac Rhythm Management
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     11.7.1. Hospitals
     11.7.2. Ambulatory SurgicalCcenters
     11.7.3. Clinics
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Cardiac Ablation Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Cardiac Ablation Devices Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by Applications
     12.4.1. Tachycardia
     12.4.2. Open Surgery
     12.4.3. Cardiac Rhythm Management
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by End Users
     12.7.1. Hospitals
     12.7.2. Ambulatory SurgicalCcenters
     12.7.3. Clinics
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Cardiac Ablation Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Cardiac Ablation Devices Market: Market Share Analysis
  13.2. Cardiac Ablation Devices Distributors and Customers
  13.3. Cardiac Ablation Devices Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Epix Therapeutics
     13.4.2. Acutus Medical
     13.4.3. Medtronic
     13.4.4. AtriCure, Inc.
     13.4.5. Biosense Webster, Inc.
     13.4.6. St Jude Medical
     13.4.7. Abbott

Purchase Premium Report

FAQ Section

Some frequently asked questions about this report!

The Cardiac Ablation Devices Market is studied from 2023 - 2031.

In 2020, electric ablators segment to account for a large market share during the forecast period.

North America held a large market share owing to the rising healthcare expenditure, increasing disposable income, and the availability of latest technology are contributing to the regional market growth.

Some of the leading manufacturers in the global cardiac ablation devices market are Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, Abbott.